glp-1 semaglutide and tirzepatide & Weight Loss Program Near Me Decoding GLP-1 Weight Loss Medications

The trial found that after 5 years, Wegovy significantly reduced the risk of death from heart disease by 15% and reduced the risk of cardiovascular events including nonfatal heart attacks and strokes by 20%, compared to an inactive placebo

2024;74:102726 (in English)

Taking exenatide enabled a reduction in the severity of psoriatic lesions, which was reported as a decrease in PASI from 11 to 34 points [83]

Relieved Joint Pain Losing weight reduces pressure on weight-bearing joints like the knees, spine, and hips, helping to slow the progression of osteoarthritis

Common Side Effects (Both Medications) Nausea ranks as the most frequent complaint